Kozak & Associates’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
QCM
YCM
EWM
MFG
COPPSERS
LTAS
CPBTD
GI
Kozak & Associates's ACLS Position: Q2 2026 in Review
Kozak & Associates held its Axcelis (ACLS) position steady in Q2 2026 at 107 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #214.
Kozak & Associates first reported a position in ACLS in Q2 2025 and has held it in 5 quarters since. 40 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Kozak & Associates held 107 shares of Axcelis worth $19.1K as of Q2 2026.
- Kozak & Associates left its Axcelis share count unchanged in Q2 2026.
- Axcelis made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #214 holding.
- Kozak & Associates first reported a position in Axcelis in Q2 2025 and has held it in 5 quarters since.
- 40 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.